Profil
Jean-Pascal Conduzorgues is currently the Chief Manufacturing Officer at OSE Immunotherapeutics SA. Prior to this, he was the President & CEO at Crid Pharma SAS, a Director at Horama SA, and the President at Amatsigroup SAS from 2011 to 2012.
Aktive Positionen von Jean-Pascal Conduzorgues
Unternehmen | Position | Beginn |
---|---|---|
OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jean-Pascal Conduzorgues
Unternehmen | Position | Ende |
---|---|---|
Amatsigroup SAS
Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Präsident | 06.06.2012 |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - |
Crid Pharma SAS
Crid Pharma SAS Pharmaceuticals: MajorHealth Technology Crid Pharma SAS specialized in Health Products Development and Clinical Supplies. The company has helped Big Pharma Groups and Biotech Companies to develop their Drug Products. The company participates in the development and registration of more than 100 products every year. On a daily basis, the company is focused on three major principles: Quality of work, Timeliness and Cost effectiveness. Crid Pharma is compliant with GMPs and ICH Guidelines. The company is authorized by French competent authorities AFSSAPS (Health Products) and AFSSA (Veterinary products). Crid Pharma was founded in August 1999 and is headquartered in Saint Gely du Fesc, France. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OSE IMMUNOTHERAPEUTICS | Health Technology |
Private Unternehmen | 3 |
---|---|
Crid Pharma SAS
Crid Pharma SAS Pharmaceuticals: MajorHealth Technology Crid Pharma SAS specialized in Health Products Development and Clinical Supplies. The company has helped Big Pharma Groups and Biotech Companies to develop their Drug Products. The company participates in the development and registration of more than 100 products every year. On a daily basis, the company is focused on three major principles: Quality of work, Timeliness and Cost effectiveness. Crid Pharma is compliant with GMPs and ICH Guidelines. The company is authorized by French competent authorities AFSSAPS (Health Products) and AFSSA (Veterinary products). Crid Pharma was founded in August 1999 and is headquartered in Saint Gely du Fesc, France. | Health Technology |
Amatsigroup SAS
Amatsigroup SAS BiotechnologyHealth Technology Amatsigroup SASU provides human and veterinary drug development services. It offers bio services, pharmaceutical analysis solutions, formulation development, and manufacturing and clinical trial supply packaging and logistics. The company was founded on October 12, 2010 and is headquartered in Fontenilles, France. | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Health Technology |